Clinical TrialsSearch results
Number of results: 314
Recruiting
- Development of a Scoring System for the Diagnostic Evaluation of Asian Patients with HFpEF
- heart failure with preserved ejection fraction
- Obokata Masaru
- 2023-11-21
Recruiting
- Effects of pharmacological treatments in heart failure with preserved ejection fraction
- Heart failure with preserved ejection fraction
- Obokata Masaru
- 2022-09-14
Recruiting
- Impact of rhythm control in patients with HFpEF and atrial fibrillation
- Heart failure with preserved ejection fraction
- Obokata Masaru
- 2022-06-04
Recruiting
- Cycle ergometer exercise catheterization for the early diagnosis of heart failure with preserved ejection fraction or pulmonary hypertension
- Heart failure with preserved ejection fraction or pulmonary hypertension
- Obokata Masaru
- 2020-09-16
Other
- Impact of comorbidities on the outcome of allogeneic hematopoietic stem cell transplantation
- hematologic diseases
- KSGCT
- 2007-11-01
Other
- JPLT2 protocol (CITA and ITEC regimen)for the pediatric liver tumor in Japan
- hepatoblastoma hepatocellular carcinoma
- Japanese Study Group for Pediatric Liver Tumors
- 2008-04-09
Recruiting
- Multi-center clinical trial of a Carbon-ion radiation therapy for unresectable and local therapy unsuitable hepatocellular carcinoma
- Hepatocellular carcinoma
- Ohno Tatsuya
- 2020-05-22
Other
- Cohort study to investigate the clinical factors associated with the prognosis of high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17
Other
- Phase 2 study of G-CSF priming chemotherapy for high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17
Other
- Phase III Randomized Adjuvant Study of Tamoxifen Alone Versus Sequential Tamoxifen and Anastrozole in Hormone-Responsive Postmenopausal Breast Cancer Patients
- Hormone-responsive postmenopausal primary breast cancer
- N-SAS BC 03 executive committee
- 2005-08-12